Peer Review reports
From: MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
Original Submission | ||
---|---|---|
19 Sep 2010 | Submitted | Original manuscript |
15 Oct 2010 | Reviewed | Reviewer Report - Frederic Blanchard |
26 Jan 2011 | Reviewed | Reviewer Report - frederique BRAUN |
18 Mar 2011 | Author responded | Author comments - Hege Ohnstad |
Resubmission - Version 2 | ||
18 Mar 2011 | Submitted | Manuscript version 2 |
24 Mar 2011 | Reviewed | Reviewer Report - Frederic Blanchard |
31 Mar 2011 | Reviewed | Reviewer Report - frederique BRAUN |
19 Apr 2011 | Author responded | Author comments - Hege Ohnstad |
Resubmission - Version 3 | ||
19 Apr 2011 | Submitted | Manuscript version 3 |
11 May 2011 | Author responded | Author comments - Hege Ohnstad |
Resubmission - Version 4 | ||
11 May 2011 | Submitted | Manuscript version 4 |
Resubmission - Version 5 | ||
Submitted | Manuscript version 5 | |
20 May 2011 | Author responded | Author comments - Hege Ohnstad |
Resubmission - Version 6 | ||
20 May 2011 | Submitted | Manuscript version 6 |
Publishing | ||
30 May 2011 | Editorially accepted | |
30 May 2011 | Article published | 10.1186/1471-2407-11-211 |
You can find further information about peer review here.